BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.,LTD.BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.,LTD.BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.,LTD.

BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.,LTD.

No trades
See on Supercharts

603392 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and equipment, and vaccines. It operates through the In Vitro Diagnostic Reagents and Vaccines segments. The In Vitro Diagnostic Reagents segment covers human immunodeficiency virus and viral hepatitis reagents, and automatic tubular chemiluminescence immunoassay systems. The Vaccines segment offers recombinant hepatitis E, human papillomavirus, and freeze-dried live attenuated varicella vaccines. The company was founded on April 24, 1991 and is headquartered in Beijing, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

603392 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company